Hood River Capital Management LLC Krystal Biotech, Inc. Transaction History

Hood River Capital Management LLC

$6.2 Billion
Q2 2025

A detailed history of Hood River Capital Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 533,023 shares of KRYS stock, worth $76.6 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

533,023

Previous 524,644 1.6%

Holding current value

$76.6 Million

Previous $94.6 Million 22.54%

% of portfolio

1.18%

Previous 1.8%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$123.36 - $181.0 $1.03 Million - $1.52 Million	8,379 Added 1.6%	533,023 $73.3 Million
Q1 2025 May 15, 2025	BUY	$142.64 - $194.44 $1.7 Million - $2.32 Million	11,918 Added 2.32%	524,644 $94.6 Million
Q4 2024 Feb 14, 2025	BUY	$156.64 - $199.61 $1.66 Million - $2.12 Million	10,622 Added 2.12%	512,726 $80.3 Million
Q3 2024 Nov 14, 2024	SELL	$174.7 - $213.66 $3.32 Million - $4.06 Million	-18,989 Reduced 3.64%	502,104 $91.3 Million
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $3.91 Million - $4.68 Million	25,507 Added 5.15%	521,093 $95.7 Million
Q1 2024 May 15, 2024	BUY	$108.01 - $179.35 $4 Million - $6.65 Million	37,073 Added 8.09%	495,586 $88.2 Million
Q4 2023 Feb 14, 2024	SELL	$96.0 - $128.29 $189,696 - $253,501	-1,976 Reduced 0.43%	458,513 $56.9 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $871,660 - $1.05 Million	8,033 Added 1.78%	460,489 $53.4 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $397,344 - $659,810	5,063 Added 1.13%	452,456 $53.1 Million
Q1 2023 May 15, 2023	BUY	$72.39 - $84.27 $1.49 Million - $1.73 Million	20,514 Added 4.81%	447,393 $35.8 Million
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $639,166 - $808,827	10,123 Added 2.43%	426,879 $33.8 Million
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $502,263 - $638,188	7,745 Added 1.89%	416,756 $29 Million
Q2 2022 Aug 15, 2022	BUY	$48.93 - $73.47 $1.18 Million - $1.78 Million	24,201 Added 6.29%	409,011 $26.9 Million
Q1 2022 May 16, 2022	BUY	$51.99 - $72.11 $8.27 Million - $11.5 Million	159,083 Added 70.48%	384,810 $25.6 Million
Q4 2021 Feb 14, 2022	SELL	$39.81 - $88.24 $6,926 - $15,353	-174 Reduced 0.08%	225,727 $15.8 Million
Q3 2021 Nov 15, 2021	SELL	$52.01 - $71.77 $461,120 - $636,312	-8,866 Reduced 3.78%	225,901 $11.8 Million
Q2 2021 Aug 13, 2021	SELL	$62.14 - $81.82 $193,566 - $254,869	-3,115 Reduced 1.31%	234,767 $16 Million
Q1 2021 May 17, 2021	SELL	$59.42 - $85.46 $1.38 Million - $1.99 Million	-23,240 Reduced 8.9%	237,882 $18.3 Million
Q4 2020 Feb 16, 2021	BUY	$40.64 - $61.38 $159,268 - $240,548	3,919 Added 1.52%	261,122 $15.7 Million
Q3 2020 Nov 16, 2020	SELL	$37.76 - $48.49 $944,302 - $1.21 Million	-25,008 Reduced 8.86%	257,203 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $10.5 Million - $16.9 Million	282,211 New	282,211 $11.7 Million

Others Institutions Holding KRYS

# of Institutions

326

Shares Held

24.7M

Call Options Held

299K

Put Options Held

97.6K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $3.69B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Account

Hood River Capital Management LLC Krystal Biotech, Inc. Transaction History